je.st
news
MassBio panel tackles why rare disease treatments cost so much
2013-03-17 19:52:04| Biotech - Topix.net
David Meeker, right, CEO of Genzyme Corp., speaks at a panel on pricing of rare disease therapies at the MassBio annual meeting.
Tags: cost
panel
disease
rare
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||